IPO Trending
INNOVACAPEQ / NSE, BSEListed

Innova Captab Limited

Incorporated in January 2005, Innova Captab Limited is a pharmaceutical company operating in three verticals – Contract Development & Manufacturing (CDMO), domestic branded generics, and international branded generics. The company manufactures a wide range of pharmaceutical products including tablets, capsules, dry syrups, injections, ointments and liquid medicines. In FY23 and Q1FY24, the company produced and sold over 600 generic products. Its domestic brands are sold through 5,000+ distributors and ~1.5 lakh retail pharmacies in India. The company also exports branded generics to 20 countries. As of October 31, 2023, Innova Captab employed 29 scientists and engineers, and has its plant in Baddi, Haryana.

₹426 - ₹44856.33x sub
Listed Price452.10
Listing Gain+0.92%
TimelineBook Built Issue IPO
Open21 Dec 2023
Close26 Dec 2023
Allotment27 Dec 2023
Listing29 Dec 2023

Quota Reservation Portions

RetailPortion: 44,53,125 shares
35%
Nii(hni)Portion: 19,08,483 shares
15%
QIBPortion: 63,61,606 shares
50%

Minimum Application Bracket Matrix

Retail1 lots / 33 shares
₹14,784
sHNI14 lots / 462 shares
₹2,06,976
bHNI68 lots / 2,244 shares
₹10,05,312

About the Company

Incorporated in January 2005, Innova Captab Limited is a pharmaceutical company operating in three verticals – Contract Development & Manufacturing (CDMO), domestic branded generics, and international branded generics. The company manufactures a wide range of pharmaceutical products including tablets, capsules, dry syrups, injections, ointments and liquid medicines. In FY23 and Q1FY24, the company produced and sold over 600 generic products. Its domestic brands are sold through 5,000+ distributors and ~1.5 lakh retail pharmacies in India. The company also exports branded generics to 20 countries. As of October 31, 2023, Innova Captab employed 29 scientists and engineers, and has its plant in Baddi, Haryana.

Company Promoters

Manoj Kumar LohariwalaVinay Kumar Lohariwala